Psychology & Psychiatry

Buprenorphine / samidorphan helpful in refractory depression

(HealthDay)—An adjunctive buprenorphine/samidorphan (BUP/SAM) combination seems beneficial for patients with major depressive disorder (MDD) with inadequate response to antidepressant therapy (ADT), according to a study ...

Psychology & Psychiatry

Anti-convulsant drug significantly reduced major depression symptoms

Researchers from the Icahn School of Medicine at Mount Sinai found that patients with Major Depressive Disorder (MDD) exhibited a significant reduction of depressive symptoms after being treated with ezogabine, an FDA approved ...

Psychology & Psychiatry

Aerobic exercise has antidepressant treatment effects

An analysis of randomized controlled clinical trials indicates that supervised aerobic exercise has large antidepressant treatment effects for patients with major depression. The systematic review and meta-analysis is published ...

Psychology & Psychiatry

Novel antidepressant may improve sleep in patients with depression

In a study of 15 patients affected by major depressive disorder and complaining of insomnia, initiating treatment with vortioxetine for their depressive symptoms led to significant improvements in subjective sleep quality ...

Neuroscience

Surprise finding in neurons

Purkinje cells are a central part of the human cerebellum, the part of the brain that plays an important role in motor learning, fine motor control of the muscle, equilibrium and posture but also influences emotions, perception, ...

Psychology & Psychiatry

New theory may explain cause of depression and improve treatments

A new area in depression research suggests dysfunction in mitochondria—the main source of energy for cells—could lead to major depression. Published in Frontiers in Neuroscience, this new insight to long-held theories ...

page 34 from 40